21895609|t|Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2.
21895609|a|Positive allosteric modulators of the ionotropic glutamate receptor-2 (GluA2) are promising compounds for the treatment of cognitive disorders, e.g. Alzheimer's disease. These modulators bind within the dimer interface of the LBD (ligand-binding domain) and stabilize the agonist-bound conformation slowing receptor desensitization and/or deactivation. In the present study, we employ isothermal titration calorimetry to determine binding affinities and thermodynamic details of binding of modulators of GluA2. A mutant of the LBD of GluA2 (LBD-L483Y-N754S) that forms a stable dimer in solution was used. The potent GluA2 modulator BPAM-97 was used as a reference compound. Evidence that BPAM-97 binds in the same pocket as the well-known GluA2 modulator cyclothiazide was obtained from X-ray structures. The LBD-L483Y-N754S:BPAM-97 complex has a Kd of 5.6 muM (DeltaH=-4.9 kcal/mol, -TDeltaS=-2.3 kcal/mol; where 1 kcal 4.187 kJ). BPAM-97 was used in a displacement assay to determine a Kd of 0.46 mM (DeltaH=-1.2 kcal/mol, -TDeltaS=-3.3 kcal/mol) for the LBD-L483Y-N754S:IDRA-21 complex. The major structural factors increasing the potency of BPAM-97 over IDRA-21 are the increased van der Waals contacts to, primarily, Met496 in GluA2 imposed by the ethyl substituent of BPAM-97. These results add important information on binding affinities and thermodynamic details, and provide a new tool in the development of drugs against cognitive disorders.
21895609	110	115	GluA2	Gene	2891
21895609	188	193	GluA2	Gene	2891
21895609	240	259	cognitive disorders	Disease	MESH:D003072
21895609	266	285	Alzheimer's disease	Disease	MESH:D000544
21895609	621	626	GluA2	Gene	2891
21895609	651	656	GluA2	Gene	2891
21895609	662	667	L483Y	ProteinMutation	tmVar:p|SUB|L|483|Y;HGVS:p.L483Y;VariantGroup:0;CorrespondingGene:2891;CorrespondingSpecies:9606
21895609	668	673	N754S	ProteinMutation	tmVar:p|SUB|N|754|S;HGVS:p.N754S;VariantGroup:1;CorrespondingGene:2891;CorrespondingSpecies:9606
21895609	734	739	GluA2	Gene	2891
21895609	750	757	BPAM-97	Chemical	MESH:C531043
21895609	806	813	BPAM-97	Chemical	MESH:C531043
21895609	857	862	GluA2	Gene	2891
21895609	873	886	cyclothiazide	Chemical	MESH:C004639
21895609	931	936	L483Y	ProteinMutation	tmVar:p|SUB|L|483|Y;HGVS:p.L483Y;VariantGroup:0;CorrespondingGene:2891;CorrespondingSpecies:9606
21895609	937	942	N754S	ProteinMutation	tmVar:p|SUB|N|754|S;HGVS:p.N754S;VariantGroup:1;CorrespondingGene:2891;CorrespondingSpecies:9606
21895609	943	950	BPAM-97	Chemical	MESH:C531043
21895609	1050	1057	BPAM-97	Chemical	MESH:C531043
21895609	1179	1184	L483Y	ProteinMutation	tmVar:p|SUB|L|483|Y;HGVS:p.L483Y;VariantGroup:0;CorrespondingGene:2891;CorrespondingSpecies:9606
21895609	1185	1190	N754S	ProteinMutation	tmVar:p|SUB|N|754|S;HGVS:p.N754S;VariantGroup:1;CorrespondingGene:2891;CorrespondingSpecies:9606
21895609	1263	1270	BPAM-97	Chemical	MESH:C531043
21895609	1350	1355	GluA2	Gene	2891
21895609	1392	1399	BPAM-97	Chemical	MESH:C531043
21895609	1549	1568	cognitive disorders	Disease	MESH:D003072
21895609	Association	MESH:C004639	2891
21895609	Bind	MESH:C531043	HGVS:p.N754S;CorrespondingGene:2891
21895609	Bind	MESH:C531043	HGVS:p.L483Y;CorrespondingGene:2891
21895609	Association	MESH:C531043	2891
21895609	Association	MESH:D000544	2891
21895609	Comparison	MESH:C004639	MESH:C531043
21895609	Association	MESH:D003072	2891

